December 2021
235 articles-
Dec 31 · 07:50Biotechnology Daily
Single Use for Manufacturing Cell-Based Therapies
-
Dec 31 · 07:48Biotechnology Daily
Flexible Sensors for Bioreactors
-
Dec 31 · 07:46Biotechnology Daily
Cell and Gene Therapy Sector Further Advised to Go Digital
-
Dec 31 · 07:44Biotechnology Daily
Cell-Based Pro-Drug Strategy for Pancreatic Cancer
-
Dec 31 · 07:43Bio Business News
Smarter Control Vital for Modern Biopharmaceutical Production
-
Dec 31 · 07:41Bio Business News
Next-Generation Viability Testing in Bioprocessing Operations
-
Dec 31 · 07:38Bio Business News
Empowering Hypoxia in Bioprocessing
-
Dec 31 · 07:31Bio Business News
TreeFrog Expands Development and Bioprocess Presence in Asia, US
-
Dec 31 · 07:07Market Watch
Xylem Inc. stock falls Thursday, still outperforms market
-
Dec 31 · 07:03Market Watch
This indicator flashed warnings in 2000 and 2007 — and it’s buzzing now
-
Dec 31 · 06:58Market Watch
Rogers Communications Inc. Cl B stock rises Thursday, outperforms market
-
Dec 31 · 06:55Market Watch
Market timer McClellan sees sharp stock-market selloff 'beginning imminently'
-
Dec 30 · 00:31Biotechnology Daily
Prostate Cancers with Enhancer Addiction Lose Their Connection
-
Dec 30 · 00:29Biotechnology Daily
Researchers Uncover Link between Bone Marrow Factors and Heart Disease
-
Dec 30 · 00:27Biotechnology Daily
Gut Flora Produces Red Meat Byproduct That Increases Heart Disease Risk
-
Dec 30 · 00:24Biotechnology Daily
Oil Degrading Microbe Grown in Lab for the First Time
-
Dec 30 · 00:22Bio Business News
DNA Repair Visualized in Detail by New Approach
-
Dec 30 · 00:18Bio Business News
Data Hoarding Poses an Existential Threat to Biopharma
-
Dec 30 · 00:15Bio Business News
Pfizer’s COVID-19 Pill Receives FDA Authorization
-
Dec 30 · 00:11Bio Business News
Benjamin Franklin Institute of Technology and Ginkgo to Create Biomanufacturing Associates Degree
-
Dec 29 · 22:50Market Watch
Dow, S&P 500 end at records Wednesday as stocks rally in final week of 2021
-
Dec 29 · 22:42Market Watch
These stocks are down at least 20% from 2021 highs, but Wall Street sees them gaining as much as 87% in 2022
-
Dec 29 · 07:54Biotechnology Daily
Biogen-Eisai's potential Aduhelm sequel drug granted speedy review by FDA
-
Dec 29 · 07:52Biotechnology Daily
BD acquires smartphone-powered COVID test partner Scanwell Health